Home Stock

Stock Research: Aurobindo Pharma

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Aurobindo Pharma

NSI:AUROPHARMA INE406A01037
72
  • Value
    84
  • Growth
    74
  • Safety
    Safety
    52
  • Combined
    77
  • Sentiment
    86
  • 360° View
    360° View
    72
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Aurobindo Pharma Limited is an India-based pharmaceutical company. It operates in the pharmaceuticals industry, focusing on active pharmaceutical ingredients, branded pharmaceuticals, and generic pharmaceuticals. The company markets its products globally in approximately 150 countries. In the last fiscal year, the company had a market cap of $7790 million, profits of $2188 million, and revenue of $3713 million.

more

ANALYSIS: With an Obermatt 360° View of 72 (better than 72% compared with alternatives), overall professional sentiment and financial characteristics for the stock Aurobindo Pharma are above average. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Aurobindo Pharma. The consolidated Value Rank has an attractive rank of 84, which means that the share price of Aurobindo Pharma is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 84% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 74, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 52. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 86. ...read more

more
Strongest Rank Opinions Change
Weakest Rank Sentiment
Country India
Industry Pharmaceuticals
Size X-Large
Website aurobindo.com
Index
Aurobindo Pharma stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 75 73 83
Growth
74 67 79 37
Safety
Safety
52 41 43 81
Sentiment
86 59 53 33
360° View
360° View
72 73 84 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
52 64 64 74
Opinions Change
31 37 53 50
Pro Holdings
n/a 72 45 16
Market Pulse
77 18 38 35
Sentiment
86 59 53 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 75 73 83
Growth
74 67 79 37
Safety Safety
52 41 43 81
Combined
77 83 85 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
67 73 82 87
Price vs. Earnings (P/E)
72 81 82 89
Price vs. Book (P/B)
77 73 80 86
Dividend Yield
63 39 34 36
Value
84 75 73 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
36 56 38 33
Profit Growth
81 42 88 58
Capital Growth
71 52 29 84
Stock Returns
77 73 100 7
Growth
74 67 79 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
48 32 40 42
Refinancing
81 78 82 90
Liquidity
44 38 40 76
Safety Safety
52 41 43 81

Similar Stocks

Discover high‑ranked alternatives to Aurobindo Pharma and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

CESC

NSI:CESC
Country: India
Industry: Electric Utilities
Size: Medium
Full Stock Analysis

Infosys

NSI:INFY
Country: India
Industry: IT Consulting & oth. Services
Size: XX-Large
Full Stock Analysis

Bharat Petroleum

NSI:BPCL
Country: India
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews